Skip to main content
SpringerLink
Log in

Biomarkers in Atrial Fibrillation: Investigating Biologic Plausibility, Cause, and Effect

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Atrial fibrillation, an increasingly common arrhythmia whose prevalence will reach epidemic proportions over the next two decades, is characterized by atrial/atrial appendage inflammation, fibrosis, remodeling, and endocardial thrombosis. Biomarkers measured within the peripheral circulation reflect these pathobiologic events with evidence of heightened thrombin generation and activity, platelet activity, fibrin formation, endocardial injury, inflammatory mediator release, and reduced fibrinolytic potential Unfortunately, the correlation between traditional biomarkers and clinical events is weak at best, as is their ability to predict successful treatment (prevention of cardioembolism) with antithrombotic agents. Future efforts devoted to the investigation of cellular biomarkers will likely provide greater practical yield and insights concerning the development, diagnosis, prognosis, and management of atrial fibrillation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Asakura H, Hifumi S, Jokaji H, et al. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis 1992;3:469–473.

    CAS  PubMed  Google Scholar 

  2. Shinohara H, Fukuda N, Soeki T, et al. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation. Jpn Heart J 1998;39:721–730.

    CAS  PubMed  Google Scholar 

  3. Sakurai K, Hirai T, Nakagawa K, et al. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter. Chest 2003;124:1670–1674.

    Article  PubMed  Google Scholar 

  4. Nakajima K. The relationship between left atrial thrombus and hematological markers in patients with chronic non-rheumatic atrial fibrillation. Jpn J Geriatrics 2000;37:903–907.

    CAS  Google Scholar 

  5. Nakagawa K, Hirai T, Shinokawa N, et al. Relation of fibrillatory wave amplitude with hemostatic abnormality and left atrial appendage dysfunction in patients with chronic nonrheumatic atrial fibrillation. Jpn Circ J 2001;65:375–380.

    Article  CAS  PubMed  Google Scholar 

  6. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997;29:106–112.

    Article  CAS  PubMed  Google Scholar 

  7. Kamath S, Chin BS, Blann AD, Lip GY. A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation. Blood Coagul Fibrinolysis 2002;13:627–636.

    Article  CAS  PubMed  Google Scholar 

  8. Nakamura Y, Nakamura K, Fukushima-Kusano K, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: Possible involvement in intracardiac thrombogenesis. Thromb Res 2003;111:137–142.

    Article  CAS  PubMed  Google Scholar 

  9. Roldan V, Martin F, Blann AD, et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 2003;24:1373–1380.

    Article  CAS  PubMed  Google Scholar 

  10. Marin F, Roldan V, Climent V, Garcia A, Marco P, Lip GY. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1? Stroke 2002;34:1181–1186.

    Article  Google Scholar 

  11. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886–2891.

    CAS  PubMed  Google Scholar 

  12. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006–3010.

    Article  PubMed  Google Scholar 

  13. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: Evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001;56:375–380.

    CAS  PubMed  Google Scholar 

  14. Abdelhadi RH, Gurm HS, Van Wagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004;93:1176–1178.

    Article  PubMed  Google Scholar 

  15. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108(Suppl):II195–II199.

    Article  PubMed  Google Scholar 

  16. Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004;62:105–111.

    Article  CAS  PubMed  Google Scholar 

  17. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: A meta-analysis of published studies. American Heart Journal 2003;146:948–957.

    Article  CAS  PubMed  Google Scholar 

  18. Poli D, Antonucci E, Cecchi E, et al. Thrombophilic mutations in high-risk atrial fibrillation patients: High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism. Thromb Haemost 2003;90:1158–1162.

    CAS  PubMed  Google Scholar 

  19. Hatzinikolaou-Kotsakou E, Kartasis Z, et al. Atrial fibrillation and hypercoagulability: Dependent on clinical factors or/and on genetic alterations? J Thromb Thrombolysis 2003;16:155–161.

    Article  CAS  PubMed  Google Scholar 

  20. Wang J, Xie X, He H, Huang J, Lu D, Yang Q. Hypercoagulability existing in the local left atrium of patients with mitral stenosis. Chin Med J 2003;116:1198–1202.

    PubMed  Google Scholar 

  21. Marin F, Roldan V, Monmeneu JV, et al. Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation. Am J Cardiol 1999;84:862–864.

    Article  CAS  PubMed  Google Scholar 

  22. Oltrona L, Broccolino M, Merlini PA, Spinola A, Pezzano A, Mannucci PM. Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation. Circulation 1997;95:2003–2006.

    CAS  PubMed  Google Scholar 

  23. Feinberg WM, Pearce LA, Hart RG, et al. Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke 1999;30:2547–2553.

    CAS  PubMed  Google Scholar 

  24. Vene N, Mavri A, Kosmelj K, Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost 2003;90:1163–1172.

    CAS  PubMed  Google Scholar 

  25. Nozawa T, Inoue H, Iwasa A, et al. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation. Circ J 2004;68:29–34.

    Article  PubMed  Google Scholar 

  26. Mitusch R, Siemens HJ, Garbe M, Wagner T, Sheikhzadeh A, Diederich KW. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 1996;75:219–223.

    CAS  PubMed  Google Scholar 

  27. Wolzt M, Bostrom SL, Svensson M, Wahlander K, Grind M, Sarich TC. Effects of the oral direct thrombin inhibitor ximelagatran on p-selectin expression and thrombin generation in atrial fibrillation. Pathophysiol Haemost Thromb 2003;33:68–74.

    Article  CAS  PubMed  Google Scholar 

  28. Muller I, Massberg S, Zierhut W, et al. Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol Haemost Thromb 2002;32:16–24.

    Article  PubMed  Google Scholar 

  29. Atak R, Turhan H, Senen K, et al. Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis. J Heart Valve Dis 2004;13:159–164.

    PubMed  Google Scholar 

  30. Goette A, Weber M, Lendeckel U, Welte T, Lutze G, Klein HU. Effect of physical exercise on platelet activity and the von-Willebrand-factor in patients with persistent lone atrial fibrillation. J Interv Card Electrophysiol 2004;10:139–146.

    Article  PubMed  Google Scholar 

  31. Goette A, Jentsch-Ullrich K, Lendeckel U, et al. Effect of atrial fibrillation on hematopoietic progenitor cells: A novel pathphysiological role of the atrial natriuretic peptide? Circulation 2003;108:2446–2449.

    Article  PubMed  Google Scholar 

  32. Rucker-Martin C, Pecker F, Godreau D, Hatem SN. Dedifferentiation of atrial myocytes during atrial fibrillation: Role of fibroblast proliferation in vitro. Cardiovasc Res 2002;55:38–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Duke Cardiovascular Thrombosis Center, Duke Clinical Research Institute, Durham, NC

    Richard C. Becker MD (Professor of Medicine, Director)

Authors
  1. Richard C. Becker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Becker, R.C. Biomarkers in Atrial Fibrillation: Investigating Biologic Plausibility, Cause, and Effect. J Thromb Thrombolysis 19, 71–75 (2005). https://doi.org/10.1007/s11239-005-0943-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-005-0943-3

Search

Navigation